[18F]JNJ-64413739

N/A

Report date: 2023/01/01 16:56:17
NME

Base Information

Drug Name[18F]JNJ-64413739
Drug Alias NameJNJ-64413739
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPositron-emission tomography enhancersRadionuclide imaging enhancers
TargetsNot applicable
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesJohnson & Johnson
China Registration ClassN/A

Develop Information

Active CompaniesJohnson & Johnson
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A